Navigation Links
Drug Targets Faulty Process That Drives Cystic Fibrosis
Date:11/17/2010

ydrated.

Overtime, the abnormal mucus builds up in the lungs and in the pancreas, which helps to break down and absorb food, causing both breathing and digestive problems.

In the lungs, the accumulation of the mucus leaves people prone to serious, hard-to-treat and recurrent infections. Overtime, the repeated infections destroy the lungs.

The average life expectancy for a person with cystic fibrosis is about 37, according to the Cystic Fibrosis Foundation.

While inhaled antibiotics and other treatments have led to substantial improvements in life expectancy, no treatments specifically target the CFTR protein. That's where VX-770 comes in, said Dr. Frank Accurso, lead study author and a professor of pediatrics at University of Colorado Denver and The Children's Hospital in Denver.

With $76 million in funding from the Cystic Fibrosis Foundation, Vertex Pharmaceuticals screened hundreds of thousands of molecules in the lab, searching for those that might work to alter the chloride channels in cystic fibrosis cells.

"You can think of the gate as being closed," Accurso said. "What this treatment does is open up the gate, allowing the chloride channel to open and the water to get out."

In the Phase II trial, 39 adults with cystic fibrosis took either the drug or a placebo for two weeks, and then again for 28 days. All patients had the G551D mutation, present in 4 to 5 percent of patients, according to the study.

Tests showed that not only did lung function improve, participants reported feeling better.

Levels of chloride in sweat also fell, indicating the drug is working on the cellular level to better regulate the release of chloride.

"That is telling us that we have improved the function of the CFTR," Accurso said.

The primary objective of the study was to evaluate the safety and tolerability of the drug. There was no difference in the frequency of reported adverse events among those taking the drug
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

0

GOOD

Page: 1 2 3

Related medicine news :

1. New Study: Improved Immune System with Gene-Eden, a Natural Antiviral Supplement that Targets Chronic Viruses
2. Hot Pepper Itch Remedy Targets Kidney Disease Patients Suffering From Chronic Pruritus
3. Scott & White Healthcare researchers studying investigational agent that targets breast cancer
4. Global Leader Readied For Healthy Aging Boom, Targets Wall Street With New Center In Trump Building
5. FDA Targets Safety Problems With Infusion Drug Pumps
6. Global Summit on International Breast Health Targets Breast Health Improvements in Developing Countries, June 9-11, 2010, in Chicago
7. Combination therapy targets stubborn leukemia stem cells
8. Miami meeting on radiation therapy targets patient safety
9. Researcher targets gene regulators on link between arsenic, cancer
10. MSU targets womens health research with $2.5 million grant
11. TGen finds therapeutic targets for rare cancer in children
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Drug Targets Faulty Process That Drives Cystic Fibrosis
(Date:6/18/2013)... 18, 2013 SEATTLE, WA—A Washington state ... Fairview, Oregon, claiming he fell ill with a hepatitis ... pomegranate seed blend. The complaint was filed in ... Clark, the Seattle-based law firm that has filed ... to the complaint, Brian Brothers consumed “Townsend Farms Organic ...
(Date:6/18/2013)... June 19, 2013 The Drug Delivery ... unprecedented access to the drug delivery partnering deals and ... , The report provides a detailed understanding and ... partnering deals. The majority of deals are discovery or ... an option right to license the license drug delivery ...
(Date:6/18/2013)... The Temp1000IS temperature data logger ... which can be used to automatically record temperatures between ... the Temp1000IS comes with the serial number and device ... (sold separately) docking station and can be placed ... more removal of end-caps to download data. The small ...
(Date:6/18/2013)... 2013 Parker Waichman LLP , ... of victims injured by defective medical devices, reports that ... Infuse bone graft products are now available. Published this ... the two studies serve up two key findings: There ... Infuse and the traditional bone graft; and there is ...
(Date:6/18/2013)... Senior drug regulatory officials from mainland China and Taiwan will ... time in the U.S.—the need for more collaboration between the ... a timely manner. Representatives from the Taiwan and mainland China ... processes in drug review during the Convergence in Regulatory ... 2013 49th Annual Meeting . , While mainland ...
Breaking Medicine News(10 mins):Health News:Marler Clark, Washington Resident Sue Townsend Farms Over Hepatitis A 2Health News:Marler Clark, Washington Resident Sue Townsend Farms Over Hepatitis A 3Health News:New Drug Delivery Partnering Terms and Agreements Market Study Report Available at MarketResearchReports.Biz 2Health News:New Drug Delivery Partnering Terms and Agreements Market Study Report Available at MarketResearchReports.Biz 3Health News:New Drug Delivery Partnering Terms and Agreements Market Study Report Available at MarketResearchReports.Biz 4Health News:MadgeTech, Inc. Introduces the New Temp1000IS Intrinsically Safe High Temperature Data Logger 2Health News:Yale Releases the Findings of the Medtronic-Commissioned Infuse Bone Graft Study; Parker Waichman LLP Comments 2Health News:Yale Releases the Findings of the Medtronic-Commissioned Infuse Bone Graft Study; Parker Waichman LLP Comments 3Health News:Renowned Regulatory Representatives From Mainland China and Taiwan to Discuss Need for Collaboration at DIA Meeting 2
... TOLOCHENAZ, Switzerland, July 14 , ... DBS Therapy for Treatment,of Chronic, Severe Obsessive-Compulsive Disorder , ... Deep Brain Stimulation (DBS),Therapy has received CE (Conformite Europeene) ... (OCD).* This is the first time that a deep ...
... Users, Guide, a comprehensive resource for endovascular and ... both book and CD formats. This unique reference ... Radiology, a national organization of physicians, scientists and ... through disease management and minimally invasive, image-guided therapeutic ...
... , KANSAS CITY, Mo., July 14 We ... make a good first impression." Do we first notice the hair, the ... of people say that a smile is the first feature we notice about ... mentally. Needless to say, we should all be interested in making sure ...
... , SCHAUMBURG, Ill., July 14 The American ... D after an updated review of the increasing body of scientific literature ... , The Academy continues to recommend that ... not from unprotected exposure to ultraviolet (UV) radiation from the sun or ...
... Center, University of Minnesota indicates that a baby born to ... many of the cancers that occur during childhood. ... advancing maternal age may be a factor and explain why, ... said Logan Spector, Ph.D., assistant professor of pediatrics and cancer ...
... , , PARSIPPANY, N.J., July ... night at the Country Music Hall of Fame in Nashville to ... dropping 2 dress sizes and just having more energy and feeling ... of whom have also made a commitment to live healthier lives. ...
Cached Medicine News:Health News:World's First Deep Brain Stimulation Device Approved for Treatment of Psychiatric Condition in Europe 2Health News:World's First Deep Brain Stimulation Device Approved for Treatment of Psychiatric Condition in Europe 3Health News:World's First Deep Brain Stimulation Device Approved for Treatment of Psychiatric Condition in Europe 4Health News:New: Interventional radiology coding users' guide 2Health News:Want to attract the opposite sex? It's in the Smile. 2Health News:American Academy of Dermatology Issues Updated Position Statement on Vitamin D 2Health News:American Academy of Dermatology Issues Updated Position Statement on Vitamin D 3Health News:American Academy of Dermatology Issues Updated Position Statement on Vitamin D 4Health News:U of M researchers find childhood cancer risk rises with mother's age 2Health News:Wynonna Judd Celebrates Her Progress on alli With Private Concert at Legendary Venue 2Health News:Wynonna Judd Celebrates Her Progress on alli With Private Concert at Legendary Venue 3
(Date:6/18/2013)... , June 18, 2013  Intercept Pharmaceuticals, Inc.  (NASDAQ: ... focused on the development and commercialization of novel bile ... the pricing of an underwritten public offering of 1,730,000 ... price of $33.01 per share.  In addition, Intercept has ... to an additional 259,500 shares of common stock. ...
(Date:6/18/2013)... 2013 Valeant Pharmaceuticals International, Inc. (NYSE: ... previously announced public offering of common shares (the "Offering"). ... common shares at a price of $85.00 per share, ... Company will file a final prospectus supplement to its ... make a similar filing with the securities regulatory authorities ...
(Date:6/18/2013)... June 18, 2013 /PRNewswire-iReach/ -- Today E-T-A Circuit ... Appliance Inlet Module. The X3130, integrated with E-T-A,s ... a C14 appliance inlet module, rocker switch and ... three-in-one device allows design engineers to streamline the ... installation time by 66 percent - and reduce ...
Breaking Medicine Technology:Intercept Pharmaceuticals Announces Pricing of Public Offering of Common Stock 2Valeant Pharmaceuticals Prices Public Offering Of Common Shares 2Valeant Pharmaceuticals Prices Public Offering Of Common Shares 3Valeant Pharmaceuticals Prices Public Offering Of Common Shares 4Three-in-One X3130 Appliance Inlet Module 2
... Calif., Sept. 8, 2011 PRO-DEX, INC. (Nasdaq: ... broadcast review of the Company,s fiscal 2011 fourth quarter and ... to be broadcast live over the internet on Wednesday, September ... Time) and may be accessed by visiting the Company,s website ...
... Panmira Pharmaceuticals, LLC and FLAP, LLC, today announced ... preceding the acquisition of Amira Pharmaceuticals, Inc. (Amira) ... received a number of assets, including Amira,s DP2 ... successfully completed Phase I clinical studies.  FLAP, LLC ...
Cached Medicine Technology:Pro-Dex, Inc. Announces Fiscal 2011 Fourth Quarter and Full-Year Financial Results Conference Call and Webcast 2Panmira and FLAP LLCs Spun Out of Amira Pharmaceuticals 2
This 16-bit integrated and cooled system is a completely self contained unit built with a long list of standard features including all-electronic-variable transilluminator and EPI lighting....
This true 8-bit integrated and cooled imaging system is a completely self contained unit built with a long list of standard features including all-electronic-variable transilluminator and EPI lightin...
... The ACS:180 SE is ... ACS:180 PLUS, consisting of important ... further simplify routine operation and ... represents the "Next Generation" ACS:180. ...
... Platelet aggregometers allows to choose the ... Single, dual and four sample units ... or digital computer outputs. In addition ... measure platelet aggregation in platelet-rich-plasma (PRP), ...
Medicine Products: